Clinical Trials: Neuroprotective Agents
- Astressin 2 studies
- Cerebrolysin 7 studies
- Cilostazol 69 studies
- Ebselen 4 studies
- Eliprodil 1 study
- Epigallocatechin gallate 38 studies
- HU 211 2 studies
- Huperzine A 8 studies
- Modafinil 148 studies
- N-acetyl-1-aspartylglutamic acid 3 studies
- Nefiracetam 1 study
- Rasagiline 40 studies
- Rivastigmine 61 studies
- Tempol 2 studies
- Tirilazad 1 study
- Topiramate 184 studies
- Vinpocetine 3 studies
- Ziconotide 5 studies
- (3-aminopropyl)(n-butyl)phosphinic acid 1 study
- 3-n-butylphthalide 3 studies
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.
The URL of this page is:
http://clinicaltrialsfeeds.org/clinical-trials/browse/intr_cat_NeuroAg
